Follow The Filings

ALL Allstate

Financials, filed as ALLSTATE CORP (COM), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2

  • 1 Owner
  • Max 0.0%
  • $35K
  • 1 add

In 2026 Q3 Kentucky Trust added to Allstate.

Who owns this now

Largest portfolio weights among holders, up to 0.0% (Kentucky Trust Co., Kentucky Trust). Not free-float ownership.

  1. Kentucky Trust Co. Add 0.02%

Who owns ALL

Sorted by value, long equity only, as of 2026 Q3.

History
Kentucky Trust Co., Kentucky Trust 0.02% Add +36.8% 160 $35K History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by ALL's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ALL insider trades
  • None no insider bought on the open market
  • $28.6M sold by 4 insiders outside a trading plan
  • $52.2M sold by 3 insiders under 10b5-1 plans
  1. Mario Rizzo COO
    Sale
    $14.9M 56,225 shares at $264.48 41% of stake
    Traded Aug 11 Filed Aug 12
    ↗
  2. John E Dugenske Insider
    Sale
    $8.9M 32,996 shares at $269.33 72% of stake
    Traded Aug 7 Filed Aug 11
    ↗
  3. Andrea Redmond Director
    Sale
    $451K 2,225 shares at $202.91 100% of stake
    Traded Jun 1 Filed Jun 2
    ↗
  4. Mark Q Prindiville Insider
    Sale
    $335K 1,550 shares at $216.27 5.3% of stake
    Traded May 22 Filed May 27
    ↗
  5. Mario Rizzo COO
    Sale
    $4.1M 18,578 shares at $218.80 18% of stake
    Traded May 1 Filed May 4
    ↗
  6. Thomas J Wilson CEO
    Planned sale
    $3.5M 16,807 shares at $208.90 18% of stake
    Traded Mar 16 Filed Mar 17
    ↗
  7. Thomas J Wilson CEO
    Planned sale
    $3.6M 16,807 shares at $212.27 15% of stake
    Traded Mar 2 Filed Mar 4
    ↗
  8. Jesse E Merten Insider
    Planned sale
    $7.1M 33,986 shares at $208.57 51% of stake
    Traded Feb 25 Filed Feb 26
    ↗
  9. Thomas J Wilson CEO
    Planned sale
    $3.5M 16,807 shares at $210.48 13% of stake
    Traded Feb 17 Filed Feb 18
    ↗
  10. Thomas J Wilson CEO
    Planned sale
    $3.4M 16,807 shares at $200.71 18% of stake
    Traded Feb 2 Filed Feb 4
    ↗
  11. Thomas J Wilson CEO
    Planned sale
    $3.5M 16,807 shares at $207.83 15% of stake
    Traded Jan 12 Filed Jan 13
    ↗
  12. Suren Gupta Insider
    Planned sale
    $4.1M 19,593 shares at $210.00 16% of stake
    Traded Jan 7 Filed Jan 8
    ↗
  13. Thomas J Wilson CEO
    Planned sale
    $3.4M 16,807 shares at $204.77 13% of stake
    Traded Jan 2 Filed Jan 6
    ↗
  14. Thomas J Wilson CEO
    Planned sale
    $3.5M 16,807 shares at $210.04 12% of stake
    Traded Dec 15, 2025 Filed Dec 17, 2025
    ↗
  15. Thomas J Wilson CEO
    Planned sale
    $3.6M 16,807 shares at $212.68 10% of stake
    Traded Dec 1, 2025 Filed Dec 3, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 45 option exercises, 35 share withholdings for taxes, 22 stock grants, and 4 gifts.

Congress

4 members of Congress traded ALL in the last three years: 1 buy and 5 sales. 7 members listed it in 2025 annual reports.

All Congress trades
  1. Michael A. Rulli R-OH-6 Sell $1K–$15K Aug 12 filed Sep 2
  2. Alan Armstrong R-OK Buy $1K–$15K Mar 27 filed Jul 21
  3. Julie Johnson D-TX-32Joint Sell $1K–$15K Apr 7, 2025 filed May 14, 2025
  4. Jared Moskowitz D-FL-23 Sell $1K–$15K Jul 5, 2024 filed Aug 19, 2024
  5. Jared Moskowitz D-FL-23Child Sell $1K–$15K Jul 5, 2024 filed Aug 6, 2024
  6. Jared Moskowitz D-FL-23Child Sell $1K–$15K Jul 5, 2024 filed Aug 6, 2024

SEC filings

Recent issuer filings from EDGAR, 10 shown.

Filed Form Detail Links
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 7.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 15 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $57.09B $64.11B $67.68B
Net income -$0.188B $4.67B $10.28B
Net margin * -0.3% 7.3% 15.2%

Balance sheet

Metric FY2023 FY2024 FY2025
Total assets $103.36B $111.62B $119.76B
Total equity $17.77B $21.44B $30.61B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $4.23B $8.93B $10.11B
Cash from investing -$3B -$8.25B -$7.26B
Cash from financing -$1.24B -$0.697B -$2.88B
Net change in cash -$14M -$18M -$26M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.